LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570–3p
2020 · Biomedical Journal · 68 citations
https://doi.org/10.1016/j.bj.2020.11.002
D
Dong Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
1.6K
Citations
22
h-index
34
i10-index
Dong Ma is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Kruppel-like factors research & RNA modifications and cancer & Cancer-related molecular mechanisms research. The author has an h-index of 22, co-authored 86 publications.
ORCID: 0009-0008-9991-4465Papers by this author
worksKLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway
2021 · BMC Cancer · 20 citations
https://doi.org/10.1186/s12885-021-08040-y
p38α in macrophages aggravates arterial endothelium injury by releasing IL-6 through phosphorylating megakaryocytic leukemia 1
2020 · Redox Biology · 18 citations
https://doi.org/10.1016/j.redox.2020.101775
Upregulation of aurora kinase A promotes vascular smooth muscle cell proliferation and migration by activating the GSK-3β/β-catenin pathway in aortic-dissecting aneurysms
2020 · Life Sciences · 15 citations
https://doi.org/10.1016/j.lfs.2020.118491
Radiomics diagnostic performance for predicting lymph node metastasis in esophageal cancer: a systematic review and meta-analysis
2024 · BMC Medical Imaging · 14 citations
https://doi.org/10.1186/s12880-024-01278-5
Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma
2024 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-024-72291-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat